Foldvari Group home

Welcome to the Foldvari Research Group   

Drug Delivery and Pharmaceutical Nanotechnology Laboratory

Foldvari Lab picture banner.Dr. Marianna Foldvari is the Canada Research Chair in Bionanotechnology and Nanomedicine and a Professor of Pharmaceutical Sciences at the University of Waterloo’s School of Pharmacy. Dr. Foldvari’s expertise is in pharmaceutics, dosage forms, drug delivery system design (dermal, transdermal, transmucosal, ocular, and intranasal), nanotechnology, non-viral delivery methods and vaccine development.

Currently, the Foldvari Group is investigating novel materials, methods, mechanisms and pathways to enable the discovery and invention of needle-free administration of medicines. We are working on developing non-invasive drug delivery technologies and pharmaceutical products based on these technologies.

Our objectives are to:

  • Develop novel delivery systems and formulations for drugs, proteins, nucleic acids and vaccines
  • Create hybrid systems, e.g., DNA-nanoparticles, carbon nanotube composites and other unique structures
  • Create nanoprobe systems for diagnostics and repair of biological functions
  • Investigate natural and synthetic materials for fabrication of delivery and diagnostic systems
  • Create interfacing methods between physical and biological systems
  • Investigate molecular functions at the bio/nano interface using computer modelling and visualization of the delivery systems


  1. Dec. 2, 20142014 Young Scholar Award

    Congratulations! - Roger Chen was recently awarded the “2014-Young Scholar Award” sponsored by Dove Medical Press. The Award was presented at the 12th Annual Current Issues in Medicine, Biotech and Pharma Conference held at Rensselaer Polytechnic Institute in Troy, New York on September 17-18, 2014.

  2. Dec. 2, 20142014 AAPS Conference, San Diego, CA

    Posters at AAPS 2014:

    Samih Alqawlaq, Jeremy M. Sivak, Torin Huzil, Marina V. Ivanova, John Flanagan, Michael A. Beazely,and  Marianna Foldvari

    Gemini-phospholipid nanoparticles as gene carriers for glaucoma gene therapy  

    Ding Wen (Roger) Chen and Marianna Foldvari

    Development and characterization of a co-culture of healthy and oxidatively stressed retinal cells as a model for evaluating gene delivery systems for the treatment of glaucoma

  3. Jan. 6, 2014Congratulations Chilbert!

    Congratulations to Chilbert Dong for successfully defending his Masters thesis titled "Characterization of Gemini Nanoparticle Assembly by Fluorescence Correlation Spectroscopy".

Read all news